Herborium Wholesale to HUT Group LLC Grows 55% in Five Months of
2017
Fort Lee, NJ -- May 31, 2017 -- InvestorsHub NewsWire
-- Herborium Group, Inc. (OTC
Pink: HBRM), www.Herborium.com, a Botanical Therapeutics
Company and the provider of unique all botanical medicines
(Botanical Therapeutics) focused on unmet medical and wellness
needs, announced today that its wholesale to HUT Group, LLC., the
largest global e commerce retailer of wellness and beauty products
increased 55% in the 5 months of 2017 in comparison to the same
period of 2016. In addition, Herborium lead product AcnEase is
designated to become a Brand of the Month on Hut Global e Commerce
Platform that will further increase sale and strengthen the brand
global image.
Herborium sales to Hut AcnEase (www.acnease.com, www.acnease.fr), its proprietary systemic, all herbal
treatment for acne, oily skin and Rosacea that contains no
chemicals and has demonstrated up to 96% efficacy in eliminating
and preventing acne breakouts. AcnEase is considered a
nutraceutical allowing Herborium to take advantage of the rapid
global growth of the burgeoning nutraceutical market. The global
nutraceutical market was valued at ~ USD 250 billion in 2016 and is
expected to reach ~ USD 385 billion by 2021.
The HUT Group websites are Europe's fastest growing online
lifestyle, health & and beauty destination. The Hut Group has
also established a growing foothold in many other geographical
regions and supports close to 200 million global website visitors,
100 million customers and over 10 million orders a year worldwide.
Their Internet e commerce destinations include such on line stores
as www.myprotein.com; www.LookFantastic.com; www.lookfanatsic.fr; www.beautyexpert.com , www.mankind.co.uk and number of ther regional websites
and on line stores.
About Herborium Group, Inc.
Herborium Group, Inc. is some botanical therapeutics company
that develops, licenses and markets proprietary, botanical based
medicinal products to consumers and healthcare professionals. The
Companys business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses clinical
validation and a proactive regulatory strategy based on the FDA
Guidance for Industry: Botanical Drug Products (FDA Guidance 2004)
to establish and maintain a differential advantage. Herborium has
secured a pipeline of botanical ingredients based products in the
areas of dermatological needs, wellness and energy, prostate
health, womens health and selected sexual disorders Herborium Group
sells its products in the United States, the United Kingdom, and
continental Europe through a network of distributors, specialty
retailers, and e-commerce. For more information, please visit
www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com
Safe Harbor Statement: This release contains forward-looking
statements with respect to the results of operations and business
of Herborium Group, Inc., which involves risks and uncertainties.
The Company's actual future results could materially differ from
those discussed. The Company intends that such statements
about the Company's future expectations, including future revenues
and earnings, and all other forward looking statements be subject
to the "Safe Harbors" provision of the Private Securities
Litigation Reform Act of 1995.
Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com
or DrAgnes@Herborium.com